Related Experiment Video
Updated: May 1, 2026

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Factor analysis of risk variables associated with iron status in patients with coronary artery disease
Vesna Spasojevic-Kalimanovska1, Natasa Bogavac-Stanojevic1, Dimitra Kalimanovska-Ostric2
1Institute of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
Insights
Inconsistent evidence links iron to coronary artery disease (CAD). This study found that iron status markers, particularly soluble transferrin receptor (sTfR), improve the prediction of CAD risk factors.
Area of Science:
- Cardiovascular Medicine
- Nutritional Science
- Biochemistry
Background:
- Epidemiological data on iron's role in atherosclerosis and coronary artery disease (CAD) are conflicting.
- Iron acts as a catalyst for lipid peroxidation, a key process in atherosclerosis.
Purpose of the Study:
- To investigate the association between body iron status and clustered cardiovascular risk factors in patients with established CAD.
- To determine if iron status indicators enhance the prediction of significant coronary artery stenosis.
Main Methods:
- Exploratory factor analysis of 15 variables in 188 patients with angiographically confirmed CAD.
- Association testing of derived factors (proatherogenic, inflammatory, antiatherogenic, obesity, antioxidative) with serum ferritin and soluble transferrin receptor (sTfR).
Main Results:
- Factor analysis identified 5 key clusters: proatherogenic, inflammatory, antiatherogenic, obesity, and antioxidative status.
- Inflammatory, obesity, and antiatherogenic factors predicted high ferritin; the proatherogenic factor predicted high sTfR.
- Including sTfR in a model with the proatherogenic factor significantly improved the prediction of coronary stenosis (AUC 0.821 vs. 0.692).
Conclusions:
- Specific cardiovascular risk factor clusters are linked to body iron status parameters.
- Soluble transferrin receptor (sTfR) measurement enhances the predictive capability for CAD when combined with established risk factors.
Objectives:
Epidemiological evidence concerning the role of iron, a lipid peroxidation catalyst, in atherosclerosis and coronary artery disease (CAD) is inconsistent.
Design And Methods:
Exploratory factor analysis was used to examine the potential clustering of variables known to be associated with CAD using data from 188 patients with angiographically-approved disease. The resulting factors were then tested for their association with serum ferritin and soluble transferrin receptor (sTfR) as indicators of body iron status.
Results:
Factor analysis resulted in a reduction of a variable number from the original 15 to 5 composite clusters. These factors were interpreted as (1) "proatherogenic factor" with positive loadings of TC, LDL-C, apoB and TG; (2) "inflammatory factor" with positive loadings of hsCRP, fibrinogen and MDA; (3) "antiatherogenic factor" with positive loadings of HDL-C and apoA-I; (4) "obesity factor" with positive loadings of weight and waist; and (5) "antioxidative status factor" with positive loadings of SOD and age and negative loading of superoxide anion. "Inflammatory", "obesity" and "antiatherogenic" factors predicted high ferritin values and the "proatherogenic factor" predicted high sTfR values. We compared the ability of the "proatherogenic factor" with that of a multivariable logistic model that included the "proatherogenic factor" and sTfR values in predicting significant stenosis in patients. The area under the ROC curve was 0.692 vs. 0.821, respectively.
Conclusions:
"Inflammatory", "obesity", "antiatherogenic" and "proatherogenic" factors were associated with increased parameters of body iron status. The measurement of sTfR improves the prediction of CAD based on clustered cardiovascular risk factors.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Coronary Artery Disease III: Clinical Manifestations
Atherosclerosis III: Management
